12 Oversold NASDAQ Stocks to Buy Now
On July 14, Max Kettner, chief multi-asset strategist at HSBC, appeared on CNBC to talk about the global markets amid trade tensions.
Vaxcyte Inc. (PCVX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 12,189,149 | $460,262,266 | +41% | 7.69% |
| 2. | Kynam Capital Derrick Tang | 3,200,000 | $120,832,000 | +37% | 10.15% |
| 3. | Commodore Capital Egen Atkinson And Michael Kramarz | 1,650,000 | $62,304,000 | +2% | 4.59% |
| 4. | Maverick Capital Lee Ainslie | 1,208,093 | $45,617,592 | +1% | 0.81% |
| 5. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,111,777 | $41,980,700 | -1% | 0.27% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.00 | 937,500 | $15,000,000.00 | 5,156,553 | 2020-06-16 | Filing | |
| $16.00 | 12,500 | $200,000.00 | 4,168,718 | 2020-06-16 | Filing | |
| $16.00 | 93,000 | $1,488,000.00 | 2,222,967 | 2020-06-16 | Filing | |
| $16.00 | 250,000 | $4,000,000.00 | 2,309,554 | 2020-06-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $72.37 | 112 | $8,105.44 | 41,620 | 2025-03-05 | Filing | |
| $71.07 | 2,267 | $161,106.62 | 41,732 | 2025-03-05 | Filing | |
| $70.39 | 2,621 | $184,486.95 | 43,999 | 2025-03-05 | Filing | |
| $73.84 | 2,085 | $153,950.15 | 154,931 | 2025-03-03 | Filing | |
| $73.07 | 5,915 | $432,214.97 | 157,016 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 83,372 | $2,710,424 | 0.02% | |
| 2. | 47,976 | $1,559,700 | 0% | |
| 3. | 3,266 | $106,178 | 0% | |
| 4. | 2,014 | $65,475 | 0.01% | |
| 5. | 1,909 | $62,062 | 0% |
News See All
Here’s Why Vaxcyte (PCVX) Sold Off in Q1
PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Cantor Fitzgerald Maintains Overweight on Vaxcyte Amid Vaccine Development and ACIP Meeting
Vaxcyte Inc. (NASDAQ:PCVX) ranks among the 30 stocks expected to beat the market by 20 percentage points this year. On June 10, Cantor Fitzgerald reiterated its Overweight rating for Vaxcyte Inc.
30 Stocks Expected To Beat the Market By 20 Percentage Points This Year
The US stock market has gone through a turbulent journey this year. Following a correction in March and a lull in April, the S&P 500 recovered its losses in May and June.
Here’s Why Vaxcyte (PCVX) Sold Off in Q1
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
11 Stocks That Will Bounce Back According to Analysts
Major US indexes finished in the green on Wednesday, May 7, after a volatile session as investors reacted to updates from the Federal Reserve and new trade developments.
11 Oversold NASDAQ Stocks to Buy Right Now
On April 28, Darrell Cronk, Wells Fargo Wealth and Investment Management CIO, appeared on CNBC's 'Squawk on the Street' to discuss market outlooks and what investors should look at in the current market...
Billionaire Stanley Druckenmiller's Top 10 Stocks Picks with Huge Upside Potential
Wall Street is overflowing with data. If companies are not releasing their earnings, economic data flows almost daily.
10 Best Debt Free Mid Cap Stocks to Buy Now
Debt-free mid-cap stocks currently offer compelling investment opportunities, especially in today's high-interest-rate environment.
10 Best Mid Cap Biotech Stocks to Buy
On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC's 'Power Lunch' to discuss investing in biotech and the oversaturation in the sector.
Billionaire Hedge Funds
